Insider Transactions in Q1 2026 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
220,000
-3.2%
|
$880,000
$4.36 P/Share
|
|
Jan 05
2026
|
Christopher Gibson Director |
SELL
Bona fide gift
|
Direct |
20,000
-2.14%
|
-
|
|
Jan 05
2026
|
Christopher Gibson Director |
SELL
Open market or private sale
|
Direct |
40,000
-4.11%
|
$160,000
$4.25 P/Share
|
|
Jan 05
2026
|
Christopher Gibson Director |
BUY
Conversion of derivative security
|
Direct |
60,000
+5.8%
|
-
|
|
Jan 02
2026
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,381
+0.19%
|
-
|
|
Jan 02
2026
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,571
+2.45%
|
-
|